When presbyopia eye drops hit the market, it brought both excitement and hesitation. The promise of presbyopia-correcting drops came with real safety concerns that gave the whole category a cautious reputation. In this mini session, Dr. Nick Bruns, Dr. Eric Fazio, and Dr. Brian Szabo discuss how Qlosi has eased those fears, and what it means for how they approach these drops with patients today.
Share
